2019
DOI: 10.2147/ijn.s191337
|View full text |Cite
|
Sign up to set email alerts
|

Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin

Abstract: PurposeRebaudioside A (RA) has nanocarrier characteristics that allow it to self-assemble into micelles in aqueous solutions. The purpose of this study was to determine if a self-nanomicellizing solid dispersion based on RA could be utilized as an oral nano-drug delivery system.Materials and methodsCurcumin (Cur) served as a model hydrophobic drug, and a Cur-loaded self-nanomicellizing solid dispersion based on RA (RA-Cur) was formulated. The properties of RA-Cur in the solid state and in aqueous solution were… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(15 citation statements)
references
References 47 publications
0
15
0
Order By: Relevance
“…A study performed on curcumin as a model drug and rebaudioside A as carrier showed that ultra-small micelles (approximately 4 nm) are formed after dissolution of the solid system (Hou et al, 2019). Authors found indications for transcytosis of these particles in the everted intestinal ring model.…”
Section: Factors Affecting Drug Uptakementioning
confidence: 99%
“…A study performed on curcumin as a model drug and rebaudioside A as carrier showed that ultra-small micelles (approximately 4 nm) are formed after dissolution of the solid system (Hou et al, 2019). Authors found indications for transcytosis of these particles in the everted intestinal ring model.…”
Section: Factors Affecting Drug Uptakementioning
confidence: 99%
“…Zhang et al [94] aimed to improve the oral absorption of baicalin, which has low solubility and poor permeability, by using a micellar formulation comprised of the carriers Pluronic P123 copolymer and sodium taurocholate. Sustained release profile of baicalin-loaded mixed micelles, in in vitro drug release experiment, held in several pH conditions, showed 14% drug released after 2 h in gastric conditions and 54% release within 48 h in intestinal conditions, compared to 34% and 79% release [105], nanoparticles [106][107][108][109][110], phytosome [111], nanoliposome [112], mixed micelles [113,114], SNEDDS [115,116], nanocarrier [117,118], nanoemulsion [119], nanosuspension [ Mixed micelles [129,130], nanoparticles [131,132], solid dispersion [133,134] , SNEDDS [135] , SMEDDS [136], lipid carrier [137], copolymeric micelles [138], exosomes [139] Naringenin DENV, HCV SNEDDS [140], solid dispersion [141], nanoparticles [142,143] , liposome [144], nanosuspension [145,146] In vitro uptake studies, carried out with a caco-2 cell line, determined the absorption of baicalin within the mixed micelles and verified their internalization ability. Baicalin-loaded ST-P123-MMs formulation achieved high oral bioavailability (Fig.…”
Section: Delivery Of Herbal Extracts and Phytochemicalsmentioning
confidence: 99%
“…Data shown in Table 8 summarize some of formulations and their pharmacokinetic properties. In order to increase curcumin bioavailability, different pharmaceutical strategies, including combination with adjuvant substances such as piperine, encapsulation, formulation in nanoparticles, liposome, micelles, nanomicellizing solid dispersion etc., have been proposed, shedding new light to overcome this pivotal limitation [214][215][216][217].…”
Section: Pharmacokinetic Deficiency Of Curcumin and Current Attemptsmentioning
confidence: 99%